Animal Genetics Market: Information, Analytical Insights and growth of 2020 – 2023

 Animal Genetics Market Overview

According to the Market Research Future (MRFR) analysis, the global animal genetics market size is estimated to register a CAGR of 8.4% from 2018 to 2023 (forecast period). The report offers an in-depth overview of the industry, including production, suppliers, quality, consumption, growth rate, profit margins, services, imports and exports, and technology advancements.

Animal genetics is a field of genetics that is dedicated to the study of genetic variability and inheritance, especially for domestic and wild animals. For commercial purposes, animal genetics is used for DNA typing, genetic disease testing, and genetic trait testing. This methodology uses a hybrid population, ontogenetic, and cytological studies to determine genetic hybridizations. For example, genetically modified cows may be able to produce more milk and may be less vulnerable to common cattle diseases, such as clostridial disease, bovine respiratory disease complex, etc., thereby increasing the overall income of cattle farmers. 

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7004

Animal Genetics Market Dynamics  

The significant factor responsible for influencing this market is the increase in the consumption of animal-derived protein, the growth of the global population, and rapid urbanization. The increasing focus on the identification of superior breeds has contributed to the growth of the market for toxicology testing. 

However, factors such as the substantial cost of animal testing, the stringent regulatory framework for genetic engineering, and the lack of qualified professionals are expected to inhibit the market growth during the forecast period. 

Animal Genetics Market Segmentation

The global market for animal genetics market is segmented based on animal genetic products, services, and end-users. 

Based on animal genetic products, the global market for animal genetics market is segmented into genetic materials and live animals. The live animals are further divided into poultry, bovine, porcine, canine, and others. The genetic materials are sub-segmented into semen and embryo. 

Based on services, the global market for animal genetics is segmented into genetic disease tests, DNA typing, gene trait tests, and others. 

Based on end-user, the global market for animal genetics is segmented into veterinary hospitals & clinics, diagnostic centers, research centers and institutes, and others. 

Animal Genetics Market Regional Analysis

Regionally, the global animal genetics market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominated the global market for animal genetics in 2017. This was due to the growth in the North American region, primarily due to factors such as growing demand for animal products such as pork and mutton. Moreover, rapid urbanization is likely to spur market demand for live animals in the coming years. Growing adoption of artificial insemination, particularly in cattle, sheep, pigs, and goats, is fueling the market growth.

Europe was the second-largest region for the global animal genetics market. Due to rising awareness of animal health, the increase in the number of numerous animal genetic diseases, and the increased prevalence of the zoonotic disease is projected to provide this market with profitable growth opportunities.

The Asia Pacific was expected to be the fastest-growing area on the global market for animal genetics in 2017. Factors due to the increasing population of livestock and the development of DNA typing and genetic testing methods further increase the demand for genetic trait tests and various diagnostic tests. 

Animal Genetics Market Key players

Some of the major participants in the global animal genetics market are Neogen Corporation (US), Genus (UK), URUS (US), Groupe Grimaud (France), Animal Genetics (US), CRV Holding B.V. (The Netherland), Topigs Norsvin (Netherlands), Zoetis (US), EW Group (Germany), Envigo (US) Hendrix Genetics BV (The Netherland), Alta Genetics (US), vetGen (US), and others.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/animal-genetics-market-7004 

Bone Growth Stimulator Market to Witness Widespread Expansion During 2020 to 2023

 Bone growth stimulators are devices which promote bone health in situations of critical fractures. These devices can use electric current to expedite the healing process. The global bone growth stimulator market report by Market Research Future (MRFR) comprises analysis of latest trends in bone repair, patents of latest devices, and market dynamics for the period of 2018 to 2023 (forecast period). The impact of the COVID-19 pandemic and its effects are also included in the report.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6962

Bone Growth Stimulator Market Scope

Global bone growth stimulator market is expected to grow significantly over the forecast period. The market held a market value of USD 1,213 million in 2017 and is projected to grow at a CAGR of 5.86% over the forecast period. Preference of electric bone stimulation in lieu of surgeries can drive the market growth. According to clinical trials conducted by the Cedars-Sinai Hospital, electric bone growth stimulators can expedite the healing process in ankle fractures. Success of these trials can pave the path for the global bone growth stimulator market.

Bone Growth Stimulator Market Segmentation

The global bone growth stimulator market has been segmented by product, application, and end user.

By product, the market has been segmented into platelet-rich plasma, bone growth stimulation devices, bone morphogenetic proteins, and others. The bone growth stimulation devices segment is further segmented into ultrasonic bone growth stimulators, external bone growth stimulators, and implanted bone growth stimulators. Among the product segment, bone growth stimulation devices are expected to account for the largest share in the global bone growth stimulator market in 2017. This is majorly attributed to the wider acceptance of the devices and better patient compliance.

On the basis of application, the market has been segmented into oral and maxillofacial surgeries, spinal fusion surgeries, delayed union & non-union bone fractures, and others. The spinal fusion surgeries segment is expected to lead in the global bone growth stimulator market in 2017.

On the basis of end users, the market has been segmented into academic and research institutes, hospitals & clinics, home care and others. The hospitals & clinics segment is expected to account for the largest share in the global bone growth stimulator market in 2017. However, growth of home care services in the developed and developing countries has been estimated to drive the segment growth during the forecast period.

Bone Growth Stimulator Market Regional Analysis

Based on the regions, the bone growth stimulator market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

Geographically, the Americas is anticipated to dominate the global bone growth stimulator market owing to the rising prevalence of the orthopedic and spinal ailments such as bone fractures and spinal damage. Development of better therapeutic approaches and advanced treatments has positively affected the regional market growth. Moreover, increasing numbers of spinal fusion procedures, patient preference for orthopedic fixation procedures, high awareness among the population, and high disposable income levels are some of the factors driving the bone growth stimulator market growth.

Europe is expected to hold the second largest market share in the global bone growth stimulator market. The market growth is majorly attributed to the increasing government support for the device manufacturers. Establishment of manufacturing units of medical device companies in this region has brought traction to bone growth stimulators.

Similarly, APAC has observed a rapid growth in the bone growth stimulator market owing to continuous developments in the healthcare sector. Moreover, increase in government funding for healthcare, a rise in R&D expenditure, and growing number of medical device companies in the region is predicted to be highly lucrative for the market in the region.

Lastly, the MEA region is anticipated to show a modest growth rate in the bone growth stimulator market during the forecast period.

Bone Growth Stimulator Market Competition

Depuy Synthes, Harvest Technologies, Orthofix International N.V., Stryker Corporation, Isto Biologics, DJO Finance LLC, Zimmer Biomet Holdings, Inc., Arthrex, Inc., Bioventus LLC, and Medtronic PLC are key players of the global bone growth stimulator market.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/bone-growth-stimulator-market-6962

Superdisintegrants Systems Market – Product Development is the best strategy for market position; Forecast till 2023

 Market Scenario:

The Global Superdisintegrants Market is anticipted to grow at an optimistic CAGR of 7.9% during the forecast period from 2018 to 2023. Disintegrants are substances which are included in drug formula to allow proper disintegration of the capsule or tablet into easily dissolvable particles. This plays a vital function in the fast absorption of medicine which increases its efficacy. Superdisintegrants are slightly modified disintegrants which offer higher efficiency than their traditional counterparts. Observed to have valued at USD 371 Mn in 2017, the global superdisintegrants market size is poised to appreciate to reach an estimated value of USD 576.2 Mn by the end of 2023.

The pharmaceutical industry is growing at breakneck speed, becoming a significant part of the healthcare sector. This is primarily due to rising populations of both geriatric patients and pediatric patients. Superdisintegrants are helpful for treatment of patients from this demographic as these tablets are easier to swallow. The growth of these demographics is expected to drive market growth. Moreover, generic drugs are in high demand as patents have begun to run out on several popular drug brands, thus opening up the pharmaceutical industry for increased entry of competition and a rise in the manufacturing of generic drugs, thus driving superdisintegrants market demand.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6663

Emerging markets represent significant opportunity as the healthcare sectors in these regions are growing at a swift pace. Moreover, large patient pools are in these countries are expected to increase demand for fast-acting medication. Market players are likely to establish themselves in the region in an effort to leverage the opportunities available in emerging economies.

Players Covered

Prominent market participants that have been profiled in the report include Asahi Kasei Corporation, DFE Pharma, JRS Pharma, Corel Pharma Chem, Ashland Global Holdings Inc., BASF SE, Roquette Freres, DowDuPont Inc., Merck KGaA, and Avantor Performance Materials, LLC

Market Segmentation

MRFR’s analysis of the various segments in the market has been performed on the basis of type, formulation, therapeutic area, and region. Types of superdisintegrants have been segmented into synthetic superdisintegrants, natural disintegrants, and others. Among these, the synthetic superdisintegrants segment has been widely used, making it the most significant market segment. However, the natural superdisintegrants segment is growing at a truly rapid pace due to the growing demand for natural ingredients.

Formulations which include superdisintegrants have been segmented into tablets and capsules. Tablets govern a majority share of the total market, while the capsules segment is expected to grow at the highest CAGR during the review period.

Therapeutic areas where superdisintegrants are used have been segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, inflammatory diseases, hematological diseases, and cardiovascular diseases. Among these segments, the gastrointestinal diseases segment is at the forefront of market growth due to the demand for fast acting medicine for these types of diseases. Meanwhile, the oncology segment is growing rapidly and is expected to display the highest CAGR over the forecast period.

Regional Analysis

Led by the U.S, the Americas have captured the largest share of the global superdisintegrants market. The presence of a developed healthcare sector as well as several important market players that have and continue to influence growth and contribute to the sizeable share that this regional market possesses. The region also has a high demand for drugs for many chronic diseases where superdisintegrants are required due to the prevalence of such diseases.

The Asia Pacific superdisintegrants market is likely to grow at the highest pace due to the concentration of rapidly emerging markets in the region. China, Japan, India, and several other country-level markets have a high demand for drugs for chronic diseases. The APAC regional market has several avenues for growth that are expected to open up in the coming years. The regions rapidly growing healthcare sector and the presence of a number of contract manufacturing organizations for pharmaceuticals is likely to have a positive impact on the market.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/superdisintegrants-market-6663

Healthcare Asset Management Market is expected to rise at a remarkable CAGR By 2023

 Healthcare Asset Management Market Overview

Healthcare asset management uses technologies such as Radiofrequency Identification (RFID) and plays a significant role in making efficient use of medical equipment, maintaining inventories, and minimizing human error. The hospital asset management system helps monitor and secure hospital facilities and uses automated software systems to track the environment on the hospital campus.

As per Market Research Future (MRFR) analysis, the healthcare asset management market is projected to grow at a CAGR of 18.2% from 2018 to 2023 (forecast period). The report on healthcare asset management is a comprehensive analysis and overview of drivers, restraints, opportunities, market trends, market size, forecasts, and developments in the healthcare asset management market. 

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6335

Healthcare Asset Management Market Dynamics

The increasing concern for patient safety, the need to make available resources more effective, and the adoption of advanced technology in the healthcare sector is expected to drive the healthcare asset management market growth. In addition, increasing investment in R&D and strategies adopted by major players such as the production of new products are contributing to market growth. For example, in August 2018, the latest version of Enterprise Asset Management (EAM) software was announced by Infor Inc., which is a major player in the healthcare asset management market.

Increasing concerns about patient safety, system accuracy problems, high deployment costs for healthcare asset management devices, and poor implementation due to organizational and infrastructure issues can impede market growth during the assessment period.

Healthcare Asset Management Market Key Players

Some of the key players in the healthcare asset management market are 

• cenTrak
• Airista Flow
• GE Healthcare
• IBM Corporation
• Infor Inc.
• Tyco Security Products.
• Intelligent InSites
• Motorola Solutions Inc.
• Radianse
• JADAK (a Novanta Company)
• Siemens Healthineers
• Sonitor Technologies
• Stanley Black & Decker Inc.
• Ekahau Inc.

Healthcare Asset Management Market Segmentation

The healthcare asset management market has been segmented on the basis of product, application, end-user, and region.

Based on the product, the market has been categorized as Real-Time Location Systems (RTLS), Radio Frequency Identification (RFID) devices and Ultrasound & Infrared Tags. The real-time location systems (RTLS) section was further divided into hardware, software, and services. The hardware section was further divided into tags/badges, and readers/interrogators.

Radio frequency identification (RFID) systems have been categorized as hardware, software, and services. The hardware section was divided into tags, readers/interrogators, and accessories. Sub-segment tags have been segmented into passive tags, and active tags. The passive tag section was slit into high-frequency (HF) tags, ultra-high-frequency (UHF) tags, and low-frequency (LF) tags. In addition, the application category has been sub-segmented in hospital asset management and pharmaceutical asset management. The hospital asset management section covers equipment monitoring and management, patient management, temperature and humidity monitoring, personnel management and prevention of diseases, and compliance with hand hygiene. The section of pharmaceutical asset management covers anti-counterfeiting drugs and supply chain management.

Based on end-user, the market has been segmented into Hospital/Clinic, Laboratories, Pharmaceutical companies, and Biotechnology.

Healthcare Asset Management Market Regional Analysis

Based on the region, the healthcare asset management market has been segmented into the Americas, Europe, the Asia Pacific, and the Middle East & Africa.

The Americas are expected to dominate the healthcare asset management market due to the introduction of technologically advanced technologies, rising demand for innovative technology to combat counterfeit drugs and the existence of a well-established healthcare system, and the presence of a large network of health service providers. According to the American Hospital Association, there were 5,534 registered hospitals in the US in 2016, about 2,000 hospitals were in rural areas and more than 3,000 hospitals were located in urban areas.

The second-largest market for controlling healthcare assets is projected to be the European market. Business growth in this area can be attributed to government funding and support for the healthcare sector, combined with increased research and development. In addition, growing cases of product counterfeiting are responsible for increasing demand for healthcare asset management services and are therefore contributing to the growth of the market in the region. According to the European Intellectual Property Office, counterfeit drugs are a major concern in the healthcare sector. Revenue of USD 11,5 billion is lost annually as a result of counterfeit drugs and 10% of all globally supplied medicines are forged.

The Asia Pacific is projected to be the fastest-growing healthcare asset management market in the forecast period due to rising demand for easy-to-use asset management tools, rising digitalization in the region, and investment in healthcare and development by market players in the region.

The market in the Middle East and Africa is projected to account for the lowest share of the healthcare asset management market due to the underdeveloped healthcare system, inadequate medical services, and lack of professional expertise. 

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/healthcare-asset-management-market-6335

About Market Research Future:

Market Research Future® has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Growth Hormone Market Estimated to Witness a Staggering Growth by 2023

 Market Research Future (MRFR’s) latest study reveals that the global market for human growth hormone will surge at an impressive CAGR of 7.50% during the review period (2018-2023). Growth hormone deficiency falls under the list of endocrine conditions. Growth hormone deficiency is prevalent across the globe and the reasons for the condition usually vary from person to person. Though the condition is rare, its prevalence rate has increased to a noteworthy level in recent times. In many cases, brain injury has been identified as a primary cause of growth hormones deficiency. Low level of growth hormone secretion can lead to altered body composition, osteoporosis, insulin resistance, lipid abnormalities, reduced energy levels, and reduced muscle strength. Low growth hormone secretion is usually an issue that starts at a young age and if not addressed promptly, may have major implications in later stages of life.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6494 

Today, the level of awareness about the condition is much higher than in the past. Modern parents show higher vigilance in monitoring their offspring’s overall physical development and are quick to react to any anomaly they observe. Increasing awareness about endocrine disorders is reflecting favourably on the global human growth hormone market. Demand for growth hormones has increased substantially. Moreover, arrival of more effective hormones has had a positive impact on the popularity of such medical products.

Global Human Growth Hormone Market: Segmental Analysis

MRFR’s report offers a thorough segmental analysis of the market on the basis of brand, route of administration, application, and distribution channel. By brand, the market has been segmented into norditropin, genotropin, mumatrope, sainzen, omnitrope and others. Among these, the norditropin segment is holds the dominant share of the market and is expected retain its positing over 2023. In 2017, the segment stood at USD 1494.98 Mn and is projected to witness a double-digit CAGR during the forecast period. By application, the market has been segmented into growth hormone deficiency, idiopathic short stature, small for gestational age, turner syndrome,

prader-willi syndrome and others. The growth hormone deficiency segment accounts for the largest share of the market and is expected to exhibit a CAGR of 7.07% during the assessment period. By route of administration, the market has been segmented into subcutaneous, intramuscular, intravenous and oral. The subcutaneous segment currently holds the leading position and accounted for more than two-third share of the market in 2017. The segment is expected to remain highly attractive throughout the assessment period. By distribution channel, the market is segmented into hospital pharmacies, clinics, retail pharmacies and e-commerce websites. The hospital pharmacies segment represented close to 40% market share in 2017 and is project to witness a health growth over the next couple of years.

Global Human Growth Hormone Market: Regional Analysis

The report covers the human growth hormone market across Americas, Asia Pacific (APAC), Europe, the Middle East & Africa. The market is Americas is expected to remain highly lucrative during the review period. In 2017, Americas commanded over 49.18% share of the market and is expected to maintain its dominant position in 2018 and beyond. Factors such as the increasing prevalence of growth hormone deficiency, high healthcare spending, and widespread awareness among consumers are partly driving the growth of the market in the region. Americas is followed by Europe and APAC respectively. Sales of human growth hormones have also picked up pace in GCC countries, which brings MEA under the radar of market players operating on a global level.

Global Human Growth Hormone Market: Competitive Landscape

Some of leading market players profiled in the report include Pfizer Inc., Novo Nordisk A/S, Anhui Anke Biotechnology Co. Ltd., Eli Lilly and Company, GeneScience Pharmaceuticals Co. Ltd., Genetech Inc., Novartis AG, Biopartners GmbH, Zhongshan Hygene Biopharm Co. Ltd., Merck KGaA, Ipsen S.A. and Lifetech Labs

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/human-growth-hormone-market-6494

Dental Restorative and Regenerative Material Market: Information, Analytical Insights and growth of 2020 – 2023

 The Global Dental Restorative and the Regenerative Material Market are expected to register a CAGR of 6.7% and is anticipated to reach USD 2679.7 Million by 2023. 

Dental restorative and regenerative materials are used to replace damaged or lost teeth, mostly it happens due to dental caries or dental cavities. Simultaneously, dental restorative and regenerative materials are also used in cosmetic dentistry, which improves the appearance of the teeth and enhances the smile of an individual.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/4332 

The increasing prevalence of dental disorders, availability of identical material, growing dental tourism, rising adherence and biocompatibility, and increasing disposable income are responsible for propelling the market growth. However, the high cost of dental restorative and regenerative material and lack of awareness about dental procedures are hampering the growth of the market.

Market Dynamics

The rise in the cases of dental complications is expected to drive the growth of the market. According to the World Dental Federation, more than 3.9 billion people are affected by oral diseases, and about half of the world’s population is suffering from untreated tooth decay. Moreover, increasing dental tourism is also likely to support market growth. On the other hand, the high cost of dental materials and lack of awareness is anticipated to hamper the market growth.

Segmentation

The global dental restorative and the regenerative material market has been segmented into type and end user. By type, the market has been segmented into restorative material and regenerative material. Restorative material segment has been divided into an amalgam, resin-base composite, glass ionomer, resin-modified glass ionomer, porcelain, metal, porcelain-fused-to-metal. The regenerative material segment is further segmented into bone graft materials, membranes, and tissue regeneration products.  

Based on end user, the market has been segmented into dental research laboratories and dental hospitals and clinics. The dental hospitals and clinics segment accounted for a market share of 82.30% in 2016.

Key Players

The prominent players in the global dental restorative and regenerative material market are DENTSPLY Sirona, Henry Schein, Inc., Kerr Corporation, Keystone Dental, Inc., Nobel Biocare Services AG, 3M, Biotech Dental, botiss biomaterials GmbH, Institut Straumann AG, and Zimmer Biomet.

Some of the key strategies followed by the players operating in the global dental restorative and regenerative material market were innovation, product development, acquisition, and expansion.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-regenerative-material-market-4332

Global Malocclusion Market Racing to a Heightened Growth by 2023

 Market Scenario

Malocclusion refers to the misalignment of teeth that can lead to serious oral health complications. Malocclusion is commonly hereditary, but it can also occur due to other reasons i.e. childhood habits such as thumb sucking, pacifier use beyond age 3, extra teeth or lost teeth, ill-fitting dental fillings, and jaw tumors. There are three major manifestations of malocclusion i.e. Class 1, Class 2, and Class 3. Class 1 malocclusion is the most common among all types. Treatment for malocclusion depends upon the severity of the condition. Treatment of malocclusion generally includes removal of teeth to correct overcrowding, braces to correct the position of the teeth, wires or plates to stabilize the jaw bone, reshaping, bonding, or capping of teeth, and surgery to reshape or shorten the jaw.

It is noted that rising prevalence of malocclusion is the key factors driving the malocclusion market. According to a study published in International Journal of Environmental Research and Public Health in 2017, it was found that prevalence of malocclusion in Shanghai is 83.9%. It is also reported that the prevalence of deep overbite was the highest in children with malocclusion i.e. 63.7%. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5094

Improvement in reimbursement scenario, and the rising trend of cosmetic dentistry are also fuelling the market growth. The techniques used for the repairing various irregularities such as discoloration, chipped teeth, and misshapen teeth or missing teeth are greatly impacting the growth of the market.

However, lack of technological awareness, and slow adoption rate in low-income countries may strongly hinder the growth of the market

The global malocclusion market is expected to grow at a CAGR of 7.0% during the forecast period 2017-2023.

Intended Audience

• Medical Devices Companies
• Hospitals & Clinics
• Diagnostic Centers
• Research and Development (R&D) Companies
• Government Research Institute
• Academic Institutes and Universities 

Segmentation

The global malocclusion market is segmented on the basis of class, treatment, and end user.

On the basis of the class, the market is classified into class I, class II, and class III.

On the basis of the treatment, the market is segmented into orthodontic braces, surgery, and others. The orthodontic braces segment is further sub-segmented into metal braces, ceramic braces, clear aligner, and others.

On the basis of the end-users, the market is segmented into hospital, clinics, dental clinics, and others.

Key Findings

• The global malocclusion market is expected to reach USD 27,720.8 million by 2023 at a CAGR of 7.0%
• On the basis of the class, Class I malocclusion is expected to command the largest market share of 41.7% over the review period and it is also expected to grow at the fastest CAGR of 7.2% during the forecast period 2017-2023
• On the basis of the treatment, orthodontic braces segment is expected to command the largest market share of 65.5% over the review period and it is also expected to grow at the fastest CAGR of 7.3% during the forecast period 2017-2023
• The Americas hold the largest share of the global malocclusion market and is expected to reach USD 11,098.3 million by 2023
• Asia Pacific is the fastest growing market, which is expected to grow at a CAGR of 7.3% over the 2017-2023

Regional Analysis

The Americas dominate the malocclusion market owing to improvements in reimbursement scenario, high healthcare expenditure, and the presence of leading players in the region. According to the American Dental Association, in the United States, Maryland, Utah, Arkansas, and Massachusetts have the highest Medicaid FFS reimbursement rates i.e. 79.3%, 75.3%, 75.2%, and 74.1% respectively, whereas, Wisconsin, California, Washington, Maine, and Iowa have the lowest coverage relative to private dental insurance reimbursement rates.

Europe holds the second position in the malocclusion market. It is expected that the support provided by the government bodies for research & development, increasing healthcare expenditure, and rising prevalence of malocclusion are propelling the growth of the malocclusion market in European region. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion, and the United Kingdom with EUR 223 billion.

Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology and the presence of huge patient pool drive the growth of this market in Asia Pacific region.

The Middle East and Africa hold the least share of the malocclusion market owing to the presence of poor and slow developing countries, especially, in African region.

Key Players

Some of key the players in the malocclusion market are 3M, A-dec Inc., Adenta GmbH, Align Technology, Inc, American Orthodontics, Biolase, Inc., Carestream Health, Inc., Danaher, DENTAURUM GmbH & Co. KG, Dentsply Sirona, G&H Orthodontics, Henry Schein, Inc., Midmark Corp., Patterson Companies, Inc., Planmeca OY, Rocky Mountain Orthodontics, Septodont Holding, TP Orthodontics, Inc, Ultradent Products Inc., Zimmer Dental Inc., and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/malocclusion-market-5094